WASHINGTON, Dec. 2 [Category: Political] -- The Human Rights Campaign issued the following news release: On December 4th, 2024, the Supreme Court will hear oral arguments for US v. Skrmetti, the first ever case addressing the constitutionality of bans on medical care for transgender youth. This case challenges Tennessee's law (Senate Bill 1), that bans affirming healthcare treatments for transgender youth in the state and could determine whether the law violates the Equal Protection Clause of t  more

WALTHAM, Massachusetts, Dec. 3 -- NEJM Evidence, a peer-reviewed journal from New England Journal of Medicine Group that says it presents clinical trial design and decision-making, published research articles on the following topics in its December 2024 edition (Vol. 3, No. 12): * American Heart Association: Adolescent Blood Pressure and Early Age Stroke * Intact Fish Skin Graft to Treat Deep Diabetic Foot Ulcers * Leg Cycle Ergometry in Critically Ill Patients -- An Updated Systematic Review  more

ITHACA, New York, Dec. 2 -- Cornell University issued the following news: Tirzepatide, a new injectable weight-loss drug with the trade name Zepbound, reduced the risk of diabetes in patients with obesity and prediabetes by more than 90% over a three-year period, compared with placebo, according to the results of a new study led by investigators at Weill Cornell Medicine, NewYork-Presbyterian, Yale School of Medicine and other institutions. The study, published Nov. 13 in the New England Journ  more